Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis.

J Genet Syndr Gene Ther

Department of Physiology and Biophysics, Chicago Medical School, North Chicago, Illinois, USA.

Published: February 2016

The recent FDA approval of two drugs to treat the basic defect in cystic fibrosis has given hope to patients and their families battling this devastating disease. Over many years, with heavy financial investment from Vertex Pharmaceuticals and the Cystic Fibrosis Foundation, pre-clinical evaluation of thousands of synthetic drugs resulted in the production of Kalydeco and Orkambi. Yet, despite the success of this endeavor, many other compounds have been proposed as therapeutic agents in the treatment of CF. Of note, several of these compounds are naturally occurring, and are present in spices from the grocery store and over the counter preparations in health food stores. In this short review, we look at three such compounds, genistein, curcumin, and resveratrol, and evaluate the scientific support for their use as therapeutic agents in the treatment of patients with CF.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828912PMC
http://dx.doi.org/10.4172/2157-7412.1000284DOI Listing

Publication Analysis

Top Keywords

therapeutic agents
12
agents treatment
12
cystic fibrosis
12
natural compounds
4
compounds therapeutic
4
treatment cystic
4
fibrosis fda
4
fda approval
4
approval drugs
4
drugs treat
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!